Biohaven Ltd. (BHVN)
Biohaven Statistics
Share Statistics
Biohaven has 102.06M shares outstanding. The number of shares has increased by 15.6% in one year.
| Shares Outstanding | 102.06M |
| Shares Change (YoY) | 15.6% |
| Shares Change (QoQ) | 0.93% |
| Owned by Institutions (%) | 97.78% |
| Shares Floating | 89.12M |
| Failed to Deliver (FTD) Shares | 32 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -4.03 and the forward PE ratio is -3.21. Biohaven's PEG ratio is -0.06.
| PE Ratio | -4.03 |
| Forward PE | -3.21 |
| PS Ratio | 0 |
| Forward PS | 1.6 |
| PB Ratio | 8.05 |
| P/FCF Ratio | -5.81 |
| PEG Ratio | -0.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Biohaven.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.49, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.49 |
| Quick Ratio | 3.49 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | -0.04 |
| Debt / FCF | -0.06 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-3.31M |
| Employee Count | 256 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 735K |
| Effective Tax Rate | -0.09% |
Stock Price Statistics
The stock price has increased by -45.29% in the last 52 weeks. The beta is 4.15, so Biohaven's price volatility has been higher than the market average.
| Beta | 4.15 |
| 52-Week Price Change | -45.29% |
| 50-Day Moving Average | 27.39 |
| 200-Day Moving Average | 38.63 |
| Relative Strength Index (RSI) | 47.1 |
| Average Volume (20 Days) | 1.35M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -885.11M |
| Net Income | -846.42M |
| EBITDA | -885.11M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -9.28 |
Balance Sheet
The company has 99.13M in cash and 32.78M in debt, giving a net cash position of 66.35M.
| Cash & Cash Equivalents | 99.13M |
| Total Debt | 32.78M |
| Net Cash | 66.35M |
| Retained Earnings | -1.35B |
| Total Assets | 615.11M |
| Working Capital | 384.25M |
Cash Flow
In the last 12 months, operating cash flow was -582.45M and capital expenditures -4.05M, giving a free cash flow of -586.5M.
| Operating Cash Flow | -582.45M |
| Capital Expenditures | -4.05M |
| Free Cash Flow | -586.5M |
| FCF Per Share | -6.43 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BHVN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for BHVN is $62, which is 184.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $62 |
| Price Target Difference | 184.5% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
Scores
| Altman Z-Score | 0.13 |
| Piotroski F-Score | 1 |